DK305087A - Buprenorphinholdigt farmaceutisk suppositorium - Google Patents

Buprenorphinholdigt farmaceutisk suppositorium

Info

Publication number
DK305087A
DK305087A DK305087A DK305087A DK305087A DK 305087 A DK305087 A DK 305087A DK 305087 A DK305087 A DK 305087A DK 305087 A DK305087 A DK 305087A DK 305087 A DK305087 A DK 305087A
Authority
DK
Denmark
Prior art keywords
buprenorphic
pharmaceutical supply
contained pharmaceutical
contained
supply
Prior art date
Application number
DK305087A
Other languages
English (en)
Other versions
DK167559B1 (da
DK305087D0 (da
Inventor
Chikamasa Yamashita
Kouzo Ishida
Gohachiro Miyamoto
Muneyoshi Ishikawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK305087D0 publication Critical patent/DK305087D0/da
Publication of DK305087A publication Critical patent/DK305087A/da
Application granted granted Critical
Publication of DK167559B1 publication Critical patent/DK167559B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK305087A 1986-06-16 1987-06-16 Buprenorphinholdigt farmaceutisk suppositorium DK167559B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61141086A JPS62298530A (ja) 1986-06-16 1986-06-16 坐薬用医薬組成物
JP14108686 1986-06-16

Publications (3)

Publication Number Publication Date
DK305087D0 DK305087D0 (da) 1987-06-16
DK305087A true DK305087A (da) 1987-12-17
DK167559B1 DK167559B1 (da) 1993-11-22

Family

ID=15283879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK305087A DK167559B1 (da) 1986-06-16 1987-06-16 Buprenorphinholdigt farmaceutisk suppositorium

Country Status (10)

Country Link
US (1) US4784855A (da)
EP (1) EP0253143B1 (da)
JP (1) JPS62298530A (da)
AT (1) ATE67932T1 (da)
CA (1) CA1283605C (da)
DE (1) DE3773440D1 (da)
DK (1) DK167559B1 (da)
ES (1) ES2039377T3 (da)
IE (1) IE59668B1 (da)
PT (1) PT85086B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
JP2007016052A (ja) * 1998-03-03 2007-01-25 Eisai R & D Management Co Ltd 抗痴呆薬を含有した経皮適用製剤又は坐剤
AU2003297074A1 (en) * 2002-12-13 2004-07-09 Euro-Celtique S.A. Transdermal buprenorphine to treat pain in sickle cell crisis
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US9415034B2 (en) * 2005-01-05 2016-08-16 National Defense Medical Center Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
EP2152315B1 (en) 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
WO2018165183A1 (en) * 2017-03-06 2018-09-13 Tactus Therapeutics, Inc. Abuse deterrent opioid formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870061A (en) * 1956-11-08 1959-01-20 Mead Johnson & Co Concentrates of dialkyl sulfosuccinates
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
DE2229770A1 (de) * 1972-06-19 1974-01-10 Boehringer Sohn Ingelheim N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
US4004010A (en) * 1972-06-19 1977-01-18 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an N-(furyl-methyl)-7α-acyl-6,14-(endoetheno or endoethano)-tetrahydro-nororipavine or -northebaine and method of use
DE2230154A1 (de) * 1972-06-21 1974-01-17 Boehringer Sohn Ingelheim N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
JPS54157820A (en) * 1978-05-30 1979-12-13 Res Inst For Prod Dev Preparation of multi-layered suppository base
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4699776A (en) * 1985-06-28 1987-10-13 R. P. Scherer Corporation Suppositories containing analgesics, antipyretics or anti-inflammatory agents

Also Published As

Publication number Publication date
DK167559B1 (da) 1993-11-22
CA1283605C (en) 1991-04-30
JPS62298530A (ja) 1987-12-25
DK305087D0 (da) 1987-06-16
ES2039377T3 (es) 1993-10-01
IE59668B1 (en) 1994-03-09
EP0253143A3 (en) 1989-08-23
PT85086B (pt) 1990-03-08
PT85086A (en) 1987-07-01
JPH0475889B2 (da) 1992-12-02
EP0253143B1 (en) 1991-10-02
EP0253143A2 (en) 1988-01-20
US4784855A (en) 1988-11-15
DE3773440D1 (de) 1991-11-07
ATE67932T1 (de) 1991-10-15
IE871522L (en) 1987-12-16

Similar Documents

Publication Publication Date Title
NZ218028A (en) Benzimidazole derivatives and pharmaceutical compositions
FI884604A0 (fi) Implanterbar, biologiskt nedbrytbart aktivmedels frigivningssystem.
ES541521A0 (es) Un procedimiento para la preparacion de piridazinaminas.
GR3004114T3 (da)
NO169638C (no) Formuleringsblanding med stabiliserende virkning paa alfa-interferon
EP0253143A3 (en) Pharmaceutical compositions for suppository
SE8404065D0 (sv) Novel biologically active compounds
IT1224405B (it) Composti attivi sul sistema cardiovascolare
SE8600658D0 (sv) Novel composition of matter
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
AU581856B2 (en) 1-(4'-alkylthiophenyl)-2-amino-1, 3-propanediol N-substituted derivatives
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
GR3007498T3 (da)
MY100752A (en) Pharmaceutical composition for combating malaria.
ZA912589B (en) A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
DE3578172D1 (de) 2,5-pyrrolidindion-derivate mit antiarrhythmischer wirkung.
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale
EP0321967A3 (en) Compounds active on the cardiovascular system

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK